Where is research today on precision medicine for multiple myeloma? Watch now to hear renowned myeloma expert Dr. Jonathan Kaufman give an important update on targeted therapies.
Published:
Dr. Robert Orlowski from The University of Texas MD Anderson Cancer Center weighs in on the flurry of myeloma news out of the ASH 2018 meeting.
Published:
Cherie Rineker, a myeloma patient, author and blogger shares her experience after having MRD testing.
Published:
Can MRD testing predict and guide multiple myeloma treatment? How should patients start the conversation with their physician about MRD testing? Myeloma expert, Dr. Jesus Berdeja weighs in.
Published:
On-site in San Diego, CA, Patient Power founder Esther Schorr is joined by leading myeloma expert Dr. Amrita Krishnan to discuss highlights from the 2018 American Society of Hematology (ASH) annual meeting. Dr. Krishnan explains what exciting research advances were made and the “top three” in treatment development for myeloma patients.
Published:
In day two of Patient Power’s daily wrap-up from the 2018 American Society of Hematology (ASH) meeting in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of leading experts to discuss impressive treatment advances and important headlines in clinical research. Watch now to find out the latest news in cancer care.
Published:
What exactly is the role of MRD testing in myeloma and is it worthwhile? Myeloma experts and patients have an in-depth conversation on how myeloma is being measured to accurately define myeloma disease states.
Published:
What course of action should myeloma patients take after a relapse? Does the nature of relapse vary from patient to patient? Watch now to hear experts Dr. Jonathan Kaufman and Dr. Rafael Fonseca explain.
Published:
How can BiTES benefit myeloma patients? Noted myeloma expert Dr. Jonathan Kaufman explains how the immunotherapy works to treat multiple myeloma and where research is today. Watch now to find out more.
Published:
